GW Henssler & Associates Ltd. increased its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,074 shares of the company’s stock after purchasing an additional 92 shares during the period. GW Henssler & Associates Ltd.’s holdings in Procter & Gamble were worth $649,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in the stock. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Northern Trust Corp raised its stake in Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after acquiring an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after acquiring an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after acquiring an additional 1,018,865 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Insiders Place Their Bets
In related news, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. The trade was a 22.57% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares in the company, valued at $4,409,221.72. The trade was a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 149,763 shares of company stock worth $23,421,279. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Stock Down 0.6%
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several analysts have weighed in on PG shares. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. Barclays cut their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. BNP Paribas Exane cut their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Finally, BNP Paribas reaffirmed an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.
Check Out Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- 3 Monster Growth Stocks to Buy Now
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- What is a Dividend King?
- Could Target’s Week of Discounts Come Full Circle for Investors?
- 3 Dividend Kings To Consider
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.